Variant report
Variant | nsv528401 |
---|---|
Chromosome Location | chr2:56706758-56712426 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189993992 | chr2:56710012-56710013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542883066 | chr2:56710013-56710014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549649854 | chr2:56710015-56710016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181502500 | chr2:56710039-56710040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186171626 | chr2:56710079-56710080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550186831 | chr2:56710121-56710122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551375720 | chr2:56710128-56710129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569479972 | chr2:56710149-56710150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190837024 | chr2:56710153-56710154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538398602 | chr2:56710160-56710161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547182411 | chr2:56710165-56710166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6738570 | chr2:56710188-56710189 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs138732504 | chr2:56710192-56710193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538622177 | chr2:56710234-56710235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs549617876 | chr2:56710264-56710265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576849870 | chr2:56710365-56710366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6753780 | chr2:56710407-56710408 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs557722540 | chr2:56710428-56710429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547101773 | chr2:56710432-56710433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577626534 | chr2:56710449-56710450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534252806 | chr2:56710460-56710461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181944921 | chr2:56710474-56710475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573748426 | chr2:56710486-56710487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149341304 | chr2:56710536-56710537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567001510 | chr2:56710550-56710551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562703754 | chr2:56710558-56710559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576399273 | chr2:56710559-56710560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs545360279 | chr2:56710573-56710574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564825274 | chr2:56710585-56710586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527289249 | chr2:56710586-56710587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56710000-56710600 | Enhancers | Muscle Satellite Cultured Cells | -- |
2 | chr2:56710000-56710600 | Enhancers | HSMM | muscle |